Early Treatment With Candesartan vs Placebo in Genetic Carriers of Dilated Cardiomyopathy (EARLY-GENE Trial)

Clinical trial NCT05321875 · RECRUITING

Trial details

NCT number: NCT05321875
Sponsor: Cristina Avendaño Solá
Status: RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Cardiomyopathy, Dilated

Start date: 2022-06-02
Primary completion: 2026-06-02
Enrollment: 320

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.